Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...

AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting ...

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the ...

Women with maternal ischemic stroke show good functional recovery but face much higher risk for cardiac disease.

The PSD-95 inhibitor also had a favorable safety profile in phase III trial ...

The American Stroke Association (ASA) announced the publication of the 2026 guideline for the early management of patients ...

When examining recovery during the first year after an ischemic stroke, a new study has found for daily tasks such as eating, dressing and driving, female participants experienced slightly worse ...

For patients after ischemic stroke, extremely low-frequency, low-intensity electromagnetic field brain stimulation reduces disability.

As stroke systems of care evolve, clinicians are increasingly torn between the known safety of traditional, aggressive ...

The American Heart Association and American Stroke Association have issued an updated guideline for the diagnosis and treatment of acute ischemic stroke.The new guideline, published in Stroke, ...

Acute ischemic stroke remains one of medicine’s most time-sensitive emergencies. When blood flow to the brain becomes blocked, approximately 1.9 million neurons die each minute without intervention.